HEPATOSPLENIC
gd T-CELL LYMPHOMA (HTCL)
is an uncommon but distinct T-cell lymphoma with a characteristic growth
pattern involving the hepatic and splenic red pulp sinusesref1,
ref2,
ref3,
ref4,
ref5,
ref6,
ref7.
Most tumors have a gd T-cell phenotype; tumors
arising from aß T-cells are clinically
and pathologically similarref.
Rare
cases of HSTCL expressing the aß chain
have been reported, but the prognostic relevance is unknownref.
The majority of patients succumb to their disease, with an overall median
survival of 16 monthsref.
The gd phenotype has been rarely identified
in primary cutaneous T-cell lymphoma and is a marker of poor prognosis
(median survival 15 months vs. 166 months in aß
subtypes)ref.
Unlike HSTCL, which express TIA1 but are negative for granzyme B and perforin
cytotoxic proteins, primary cutaneous gd TCL
express all cytotoxic proteins, thus demonstrating an activated T-cell
phenotype which may contribute to their aggressive behaviorref.
gd T-cells are normally the first line of defense
at epidermal and epithelial surfaces and they represent 10-12% of lymphocytes
in the spleenref1,
ref2 Epidemiology : most cases occur in young
adult males (median age, 29-34 yrs)
Aetiology : approximately 20% arise in
immunosuppressed, predominantly posttransplant patientsref1,
ref2,
ref3 Symptoms & signs : B symptoms, splenomegaly
(98%), hepatomegaly (80%), no lymphadenopathy, anemia, and severe thrombocytopenia
(80-85%).
Laboratory examinations : bone marrow
involvement
cytomorphology : the tumor cells are homogeneous, medium-sized lymphocytes
with partially dispersed chromatin, inconspicuous nucleoli and generally
little cytologic atypia. Circulating tumor cells are present in the blood
in 25-50% or more of patients during the course of disease. On Wright's
stain the cells have partially condensed chromatin and pale blue cytoplasm.
The presence of cytoplasmic granules is variable, but most report the cells
are agranular. Marrow involvement is present in approximately 66% of cases
but is usually subtle involving the sinuses. Immunoperoxidase staining
for T-cell antigens is important to aid in recognitionref1,
ref2
cytogenetics : HCTL has a recurrent chromosome abnormality, isochromosome
7q, that appears to be the primary genetic event in its pathogenesisref1,
ref2,
ref3,
ref4,
ref5.
Trisomy 8 is a common cytogenetic abnormality
immunophenotype : CD2+3+4-5-7+8-,
rarely +16+56+57-,
TcRgd+; HTCL arises from an CD4-
CD8- T cell or, in 15%, a CD4- CD8+ T-cell.
The NK-cell associated antigen CD56 is expressed in 60-70% of cases, so
many of these cases have an NK-like T-cell phenotype. TIA-1 is present
in virtually all cases, but approximately 50% lack granzyme B and or perforin,
indicating a non-activated cytolytic T-cell phenotype.
Therapy : most patients are refractory or
have brief responses to anthracycline therapy with death occurring <
1 year after diagnosisref1,
ref2.
Differential diagnosis :
large granular lymphocyte (LGL) leukemia which usually occurs in older
patients often with a history of rheumatologic disease, is indolent, and
most often arises from CD57+ rather than CD56+ T-cellsref1,
ref2
aggressive NK-cell leukemia may present with hepatosplenomegaly but morphologically
the tumor has a more blastic cytology and expresses all cytolytic proteins
whereas hepatosplenic lymphoma usually expresses TIA-1 only and lacks granzyme
B and perforinref1,
ref2,
ref3,
ref4,
ref5,
ref6
CD8+ T-cell CLL is a rare disease that has more marrow involvement
than hepatosplenic lymphoma and it lacks cytolytic granules and NK-cell
associated antigensref.